Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Systematic review of cost-effectiveness studies of human papillomavirus (HPV) vaccination: 9-Valent vaccine, gender-neutral and multiple age cohort vaccination
Siok Shen Ng, Raymond Hutubessy, Nathorn Chaiyakunapruk
Vaccine (2018) Vol. 36, Iss. 19, pp. 2529-2544
Closed Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

Penile cancer
Anita Thomas, Andrea Necchi, Asıf Muneer, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Closed Access | Times Cited: 168
Human papillomavirus vaccination and cervical cancer risk
Lisa Rahangdale, Chemtai Mungo, Siobhán O’Connor, et al.
BMJ (2022), pp. e070115-e070115
Open Access | Times Cited: 93
Gender neutral HPV vaccination programs: Reconsidering policies to expand cancer prevention globally
J. Andrew Dykens, Caryn E. Peterson, Hunter K. Holt, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 45
Human papillomavirus vaccination uptake in low-and middle-income countries: a meta-analysis
Thinley Dorji, Tanawin Nopsopon, Saran Tenzin Tamang, et al.
EClinicalMedicine (2021) Vol. 34, pp. 100836-100836
Open Access | Times Cited: 76
Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis
Mélanie Drolet, Jean‐François Laprise, Dave Martin, et al.
The Lancet Infectious Diseases (2021) Vol. 21, Iss. 11, pp. 1598-1610
Open Access | Times Cited: 65
Human papillomavirus vaccination in the European Union/European Economic Area and globally: a moral dilemma
Edoardo Colzani, Kari Johansen, Helen Johnson, et al.
Eurosurveillance (2021) Vol. 26, Iss. 50
Open Access | Times Cited: 64
HPV Vaccination: An Underused Strategy for the Prevention of Cancer
Gilla K. Shapiro
Current Oncology (2022) Vol. 29, Iss. 5, pp. 3780-3792
Open Access | Times Cited: 62
HPV-FRAME: A consensus statement and quality framework for modelled evaluations of HPV-related cancer control
Karen Canfell, Jane J. Kim, Shalini Kulasingam, et al.
Papillomavirus Research (2019) Vol. 8, pp. 100184-100184
Open Access | Times Cited: 51
Assessment of Knowledge, Attitudes, and Propensity towards HPV Vaccine of Young Adult Students in Italy
Cecilia Trucchi, Daniela Amicizia, Silvio Tafuri, et al.
Vaccines (2020) Vol. 8, Iss. 1, pp. 74-74
Open Access | Times Cited: 41
Cost and effectiveness of HPV vaccine delivery strategies: A systematic review
Alvine Akumbom, Jennifer Lee, Nancy Reynolds, et al.
Preventive Medicine Reports (2022) Vol. 26, pp. 101734-101734
Open Access | Times Cited: 24
The socioeconomic burden of cervical cancer and its implications for strategies required to achieve the WHO elimination targets
Julia Brotherton, Claire M. Vajdic, Claire Nightingale
Expert Review of Pharmacoeconomics & Outcomes Research (2025)
Closed Access
A cost-effectiveness analysis of adult human papillomavirus vaccination strategies in Italy
Alhaji Cherif, Cody Palmer, Francesca Senese, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Public health impact and cost effectiveness of routine and catch-up vaccination of girls and women with a nine-valent HPV vaccine in Japan: a model-based study
Cody Palmer, Keisuke Tobe, Machiko Abe, et al.
BMC Infectious Diseases (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 31
HPV Vaccination: Does It Have a Role in Preventing Penile Cancer and Other Preneoplastic Lesions?
Laura Elst, Maarten Albersen
Seminars in Oncology Nursing (2022) Vol. 38, Iss. 3, pp. 151284-151284
Closed Access | Times Cited: 20
Vaccination against HPV: boosting coverage and tackling misinformation
Janne Bigaard, Silvia Franceschi
Molecular Oncology (2020) Vol. 15, Iss. 3, pp. 770-778
Open Access | Times Cited: 31
Impact of knowledge and attitude on the utilization rate of cervical cancer screening tests among Ethiopian women: A systematic review and meta-analysis
Ayelign Mengesha Kassie, Biruk Beletew Abate, Mesfin Wudu Kassaw, et al.
PLoS ONE (2020) Vol. 15, Iss. 12, pp. e0239927-e0239927
Open Access | Times Cited: 29
A systematic review of the barriers to implementing human papillomavirus vaccination programs in low‐ and middle‐income countries in the Asia‐Pacific
Abbygail Therese Ver, Kin Israel Notarte, Jacqueline Veronica Velasco, et al.
Asia-Pacific Journal of Clinical Oncology (2021) Vol. 17, Iss. 6, pp. 530-545
Closed Access | Times Cited: 26
Looking Back, Moving Forward: Challenges and Opportunities for Global Cervical Cancer Prevention and Control
Philip E. Castle
Viruses (2024) Vol. 16, Iss. 9, pp. 1357-1357
Open Access | Times Cited: 3
Dynamic factors affecting HPV-attributable fraction for head and neck cancers
Jitesh B. Shewale, Maura L. Gillison
Current Opinion in Virology (2019) Vol. 39, pp. 33-40
Closed Access | Times Cited: 28
Cost-effectiveness evaluations of the 9-Valent human papillomavirus (HPV) vaccine: Evidence from a systematic review
Rashidul Alam Mahumud, Khorshed Alam, Syed Afroz Keramat, et al.
PLoS ONE (2020) Vol. 15, Iss. 6, pp. e0233499-e0233499
Open Access | Times Cited: 25
Relevance of Human Papillomaviruses in Head and Neck Cancer—What Remains in 2021 from a Clinician’s Point of View?
Markus Hoffmann, Elgar Susanne Quabius
Viruses (2021) Vol. 13, Iss. 6, pp. 1173-1173
Open Access | Times Cited: 17
Gender‐neutral HPV elimination, cervical cancer screening, and treatment: Experience from Bhutan
Thinley Dorji, Ugyen Tshomo, Sonam Gyamtsho, et al.
International Journal of Gynecology & Obstetrics (2021) Vol. 156, Iss. 3, pp. 425-429
Open Access | Times Cited: 16
Public health impact and cost-effectiveness of switching from bivalent to nonavalent vaccine for human papillomavirus in Norway: incorporating the full health impact of all HPV-related diseases
I. Diakité, Sylvi Nguyen, Ugne Sabale, et al.
Journal of Medical Economics (2023) Vol. 26, Iss. 1, pp. 1085-1098
Open Access | Times Cited: 6
Simultaneously characterizing the comparative economics of routine female adolescent nonavalent human papillomavirus (HPV) vaccination and assortativity of sexual mixing in Hong Kong Chinese: a modeling analysis
Cheuk‐Wai Choi, Mark Jit, GM Leung, et al.
BMC Medicine (2018) Vol. 16, Iss. 1
Open Access | Times Cited: 19
Development and acceptability of a peer-paired, cross-cultural and cross-generational storytelling HPV intervention for Korean American college women
Minjin Kim, Haeok Lee, Peter Nien‐chu Kiang, et al.
Health Education Research (2019) Vol. 34, Iss. 5, pp. 483-494
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top